Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Replimune Group, Inc. Director's Dealing 2023

Nov 18, 2023

33193_dirs_2023-11-17_7a94c3e1-8cc1-4840-a702-c25c72c1a497.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Replimune Group, Inc. (REPL)
CIK: 0001737953
Period of Report: 2023-11-16

Reporting Person: Sarchi Christopher (Chief Commercial Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2023-11-16 Common Stock S 5255 $10.92 Disposed 72245 Direct

Footnotes

F1: Represents shares of the Issuer's common stock sold to cover tax withholding obligations in connection with the partial vesting of the Reporting Person's Restricted Stock Units ("RSU"). The transaction reported herein was made in accordance with the irrevocable "sell to cover" provision set forth in the award agreement under which the RSU was granted and does not represent a discretionary sale by the Reporting Person.

F2: The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.92 to $11.21. The Reporting Person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.